Literature DB >> 22023316

Stigma mediates the relationship between self-efficacy, medication adherence, and quality of life among people living with HIV/AIDS in China.

Xianhong Li1, Ling Huang, Honghong Wang, Kristopher P Fennie, Guoping He, Ann B Williams.   

Abstract

Although the relationship between self-efficacy and health-related behaviors is well known, limited data are available describing the association between self-efficacy and HIV stigma. Specifically, it is not known if the relationship between self-efficacy and health outcomes is mediated by HIV stigma. This study aimed to test these relationships. Data were collected from 202 HIV/AIDS patients in China using questionnaires measuring self-efficacy for disease management, self-reported 7 day medication adherence, perceived HIV/AIDS stigma and quality of life. The total mean score for self-efficacy was 6.73 (range, 2.78-10.0), and the total mean score for HIV stigma was 102.24 (range, 57.0-148.0). Seventy-four percent (150/202) of subjects reported missing no medication doses during past 7 days, and 73% (148/202) subjects reported a quality of life score over 60. There was a moderate level of association between self-efficacy and HIV stigma (Pearson r=-0.43, p=0.000). High self-efficacy predicted better medication adherence (odds ratio [OR]=1.82, 95% confidence interval [CI]=1.40-2.36) and better quality of life (OR=1.28, 95% CI=1.03-1.60) after controlling for demographic and HIV related characteristics. HIV stigma partially mediated the relationship between self-efficacy and medication adherence (OR=1.64, 95% CI=1.26-2.15; Sobel test result Z=1.975, p=0.048). HIV stigma totally mediated the relationship between self-efficacy and quality of life (OR=1.15, 95% CI=0.91-1.46; Sobel test result Z=2.362, p=0.018). The results suggest that, although self-efficacy is an important predictor for medication adherence and quality of life, HIV stigma as a mediator should not be neglected. Health care providers should also evaluate HIV stigma conditions when seeking to improve self-efficacy through interventions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22023316      PMCID: PMC3279711          DOI: 10.1089/apc.2011.0174

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  30 in total

1.  The personal experiences of HIV/AIDS patients in rural areas of western China.

Authors:  Zhang Shao-Ru; Yan Hong; Li Xiao-Hong; Pan Jian-Ping; Yao Wan-Xia; Zhang Hua; Luo Sha-Sha
Journal:  AIDS Patient Care STDS       Date:  2010-07       Impact factor: 5.078

2.  Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.

Authors:  E L Murphy; A C Collier; L A Kalish; S F Assmann; M F Para; T P Flanigan; P N Kumar; L Mintz; F R Wallach; G J Nemo
Journal:  Ann Intern Med       Date:  2001-07-03       Impact factor: 25.391

3.  Inequality and unwillingness to care for people living with HIV/AIDS: a survey of medical professionals in Southeast China.

Authors:  Guoxi Cai; Kazuhiko Moji; Sumihisa Honda; Xiaonan Wu; Konglai Zhang
Journal:  AIDS Patient Care STDS       Date:  2007-08       Impact factor: 5.078

4.  Development and validation of a condom self-efficacy scale for college students.

Authors:  L J Brafford; K H Beck
Journal:  J Am Coll Health       Date:  1991-03

5.  Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG).

Authors:  M A Chesney; J R Ickovics; D B Chambers; A L Gifford; J Neidig; B Zwickl; A W Wu
Journal:  AIDS Care       Date:  2000-06

6.  Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System.

Authors:  Ann E Deschamps; Veerle D E Graeve; Eric van Wijngaerden; Veerle De Saar; Anne-Mieke Vandamme; Kristien van Vaerenbergh; Helga Ceunen; Herman Bobbaers; Willy E Peetermans; Peter J de Vleeschouwer; Sabina de Geest
Journal:  AIDS Patient Care STDS       Date:  2004-11       Impact factor: 5.078

7.  The Chinese free antiretroviral treatment program: challenges and responses.

Authors:  Fujie Zhang; Jessica E Haberer; Yu Wang; Yan Zhao; Ye Ma; Decai Zhao; Lan Yu; Eric P Goosby
Journal:  AIDS       Date:  2007-12       Impact factor: 4.177

8.  Preliminary evidence that self-efficacy predicts physical activity in multiple sclerosis.

Authors:  Robert W Motl; Edward McAuley; Shawna Doerksen; Liang Hu; Katherine S Morris
Journal:  Int J Rehabil Res       Date:  2009-09       Impact factor: 1.479

9.  Behavioral correlates of adherence to antiretroviral therapy.

Authors:  Maria Stella Aloisi; Claudio Arici; Roberta Balzano; Pasquale Noto; Rita Piscopo; Gaetano Filice; Francesco Menichetti; Antonella d'Arminio Monforte; Giuseppe Ippolito; Enrico Girardi
Journal:  J Acquir Immune Defic Syndr       Date:  2002-12-15       Impact factor: 3.731

10.  Medication adherence mediates the relationship between adherence self-efficacy and biological assessments of HIV health among those with alcohol use disorders.

Authors:  Jeffrey T Parsons; Elana Rosof; Brian Mustanski
Journal:  AIDS Behav       Date:  2007-05-15
View more
  29 in total

1.  Prospective cohort study of the impact of antiretroviral therapy on employment outcomes among HIV clients in Uganda.

Authors:  Sebastian Linnemayr; Peter Glick; Cissy Kityo; Peter Mugyeni; Glenn Wagner
Journal:  AIDS Patient Care STDS       Date:  2013-12       Impact factor: 5.078

2.  Nurse-delivered counselling intervention for parental HIV disclosure: results from a pilot randomized controlled trial in China.

Authors:  Jane M Simoni; Joyce P Yang; Cheng-Shi Shiu; Wei-Ti Chen; Wadiya Udell; Meijuan Bao; Lin Zhang; Hongzhou Lu
Journal:  AIDS       Date:  2015-06       Impact factor: 4.177

3.  Disclosing Parental HIV Status to Children in China: Lessons Learned Through an Intervention Study.

Authors:  Lin Zhang; Wei-Ti Chen; Joyce P Yang; Jane M Simoni; Chengshi Shiu; Meijuan Bao; Jing Zhang; Meiyan Sun; Yang Qiu; Hongzhou Lu
Journal:  J Assoc Nurses AIDS Care       Date:  2016-09-22       Impact factor: 1.354

4.  Psychosocial and Service Use Correlates of Health-Related Quality of Life Among a Vulnerable Population Living with HIV/AIDS.

Authors:  Mary M Mitchell; Trang Q Nguyen; Sarina R Isenberg; Allysha C Maragh-Bass; Jeanne Keruly; Amy R Knowlton
Journal:  AIDS Behav       Date:  2017-06

Review 5.  Biomedical risk, psychosocial influences, and developmental outcomes: lessons from the pediatric HIV population in Africa.

Authors:  Amina Abubakar
Journal:  New Dir Child Adolesc Dev       Date:  2014

6.  Stigma Determines Antiretroviral Adherence in Adults With HIV in Myanmar.

Authors:  Su Aung; Nicole Hardy; Stavroula A Chrysanthopoulou; Aung Kyaw; Min San Tun; Khaymar Win Aung; Aadia Rana; Rami Kantor
Journal:  J Acquir Immune Defic Syndr       Date:  2022-01-01       Impact factor: 3.771

7.  The role of emotions in the reduction of HIV/AIDS stigma among physicians in training.

Authors:  Nelson Varas-Díaz; Torsten B Neilands; Sheilla L Rodríguez-Madera; Mark Padilla
Journal:  AIDS Care       Date:  2015-10-07

Review 8.  The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review.

Authors:  Sandra A Springer; Azem Dushaj; Marwan M Azar
Journal:  AIDS Behav       Date:  2012-11

9.  Associations between perceived HIV stigma and quality of life at the dyadic level: the actor-partner interdependence model.

Authors:  Hongjie Liu; Yongfang Xu; Xinjin Lin; Jian Shi; Shiyi Chen
Journal:  PLoS One       Date:  2013-02-01       Impact factor: 3.240

10.  HIV-related stigma and physical symptoms have a persistent influence on health-related quality of life in Australians with HIV infection.

Authors:  Susan Herrmann; Elizabeth McKinnon; Noel B Hyland; Christophe Lalanne; Simon Mallal; David Nolan; Olivier Chassany; Martin Duracinsky
Journal:  Health Qual Life Outcomes       Date:  2013-04-08       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.